BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4333395)

  • 1. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alpha-methyldopa and of spironolactone on angiotensin responsiveness in man.
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Ther Hung; 1972; 20(4):148-9. PubMed ID: 4366411
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of alpha methyldopa and phenobarbital on angiotensin sensitivity and renin activity in man].
    Káldor A; Gachályi B; Kállay K; Fekete S; Földvári A
    Orv Hetil; 1975 Jan; 116(1):9-11. PubMed ID: 1088983
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of clonidine (Haemiton) on plasma renin level and angiotensin sensitivity in man.
    Gachályi B; Káldor A
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):433-6. PubMed ID: 700917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alphamethyldopa and of phenobarbitone on angiotensin responsiveness and renin activity in man.
    Káldor A; Gachályi B; Kállay K; Fekete S; Földvári A
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):10-4. PubMed ID: 1150359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM; Suthers MB; Friedman A; Johnston CI
    Med J Aust; 1978 May; 1(9):509-12. PubMed ID: 353458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
    Solheim SB; Sundsfjord JA; Giezendanner L
    Acta Med Scand; 1975 Jun; 197(6):451-6. PubMed ID: 1098396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of guanethidine and of reserpine on angiotensin responsiveness in man.
    Kállay K; Káldor A; Gachalyi B; Sebestyén
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):35-9. PubMed ID: 1150361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
    Cagli V
    Clin Ter; 1976 Feb; 76(3):253-60. PubMed ID: 963964
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.
    Lowder SC; Liddle GW
    N Engl J Med; 1974 Dec; 291(23):1243-4. PubMed ID: 4422945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
    Pessina AC; Corgnati A; Palù CD
    Minerva Med; 1977 Feb; 68(8):509-14. PubMed ID: 846681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pressor effect of angiotensin II and norepinephrine in patients with hypertension treated with alpha methyldopa].
    Imbs JL; Spach MO; Velly J; Desaulles E
    Therapie; 1972; 27(5):937-46. PubMed ID: 4346780
    [No Abstract]   [Full Text] [Related]  

  • 15. EPFFECT OF PROPRanolol on plasma renin level and angiotensin sensitivity in man.
    Gachályi B; Káldor A; Kállay K
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):196-8. PubMed ID: 950262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to advance antihypertensive therapy].
    Ménard J; Corvol P; Alexandre JM; Milliez P
    Nouv Presse Med; 1974 Feb; 3(5):253-6. PubMed ID: 4362250
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

  • 18. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
    Adlin EV; Marks AD; Channick BJ
    Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
    Thomas GW; Ledingham JG; Beilin LJ; Yeates KM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
    Esch I; Placheta P
    Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.